Table 1.
Baseline characteristics
| Patient 1 | Patient 2 | Patient 3 | |
|---|---|---|---|
| Age | 76 | 59 | 60 |
| Gender | Female | Male | Male |
| Race | Hindu | Caucasian | Caucasian |
| Length, cm | 168 | 196 | 170 |
| Weight, kg | 99 | 98 | 76.9 |
| BMI, kg/m2 | 35.2 | 25.6 | 26.6 |
| Mean office blood pressure (mm Hg) | 193/93 | 173/115 | 195/98 |
| Mean ambulatory blood pressure (mm Hg) | 173/101 | 161/107 | 164/98 |
| Diabetes | No | No | Yes |
| Hypercholesterolaemia | No | No | Yes |
| Current smoking status | No | No | Yes, 20 PY |
| eGFR, ml/min | 56 | 72 | 90 |
| Coronary artery disease | No | No | No |
| Peripheral artery disease | Yes | No | No |
| History of stroke | Yes | No | No |
| Antihypertensive medication | |||
| Ace inhibitor | Yes | No | No |
| Angiotensin receptor blocker | No | Yes | Yes |
| Diuretic | Yes | Yes | Yes |
| Calcium channel blocker | Intolerant | Yes | Yes |
| Alpha blocker | No | Yes | Yes |
| Beta blocker | Yes | Yes | Yes |
| Aldosterone receptor antagonist | No | No | No |
| Vasodilator | No | No | Yes |
| Previously used RDN device | Recor Paradise 3 ablations/artery |
Vessix 8 ablations/artery |
Covidien 1 ablation/artery |
| Office blood pressure before initial treatment | 207/93 | 165/100 | 184/103 |
| Ambulatory blood pressure before initial treatment | 155/75 | 161/109 | 162/98 |
| Change in office blood pressure 1 year after 1st procedure | −14/0 | +8/+15 | +11/−5 |
| Change in ambulatory blood pressure after 1st procedure | +18/26 | 0/−2 | +2/0 |